CDKN1B and chronic myelogenous leukemia, BCR-ABL1 positive: We observed a similar effect in our study; inhibition of p210Bcr-Abl in primary CML cells and K562 cells increased the total p27kip1 as well as cytoplasmic p27kip1 expression.